A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib
about
A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Study of Brigatinib in Parti ...... ssed on Alectinib or Ceritinib
@en
type
label
A Study of Brigatinib in Parti ...... ssed on Alectinib or Ceritinib
@en
prefLabel
A Study of Brigatinib in Parti ...... ssed on Alectinib or Ceritinib
@en
P17
P6153
P131
P1476
Brigatinib in Patients With An ...... ssed on Alectinib or Ceritinib
@en
P1813
ALTA-2
@en
P3098
NCT03535740
P4844
P580
2019-01-31T00:00:00Z
P582
2019-12-18T00:00:00Z